Molecule Details
| InChIKey | LKAJKIOFIWVMDJ-IYRCEVNGSA-N |
|---|---|
| Compound Name | Stanozolol |
| Canonical SMILES | C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.27 |
| Source | ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB06718 |
|---|---|
| Drug Name | Stanozolol |
| CAS Number | 10418-03-8 |
| Groups | approved vet_approved |
| ATC Codes | A14AA02 |
| Description | Stanozolol is a synthetic anabolic steroid with therapeutic uses in treating hereditary angioedema. Stanozolol is derived from testosterone, and has been abused by several high profile professional athletes. |
Categories: Alimentary Tract and Metabolism Anabolic Agents Anabolic Agents for Systemic Use Anabolic Steroids Androgens Androstan Derivatives Androstanes Androstanols Fused-Ring Compounds Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Steroids Thyroxine-binding globulin inhibitors
Cross-references: ChEBI: 9249 CHEMBL2079587 ChemSpider: 23582 Drugs Product Database (DPD): 7457 C07311 D00444 PDB: A1IOS PharmGKB: PA165958391 PubChem:25249 PubChem:99443270 RxCUI: 10032 Wikipedia: Stanozolol ZINC: ZINC000004097376
Target Activities (2)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P10275 | AR | Androgen receptor | agonist | targets |